CAR-based cell therapy: evaluation with bibliometrics and patent analysis

Yajun Yuan1, Qihan Fu2, Yaqun Zhang3

  • 1Zhejiang Academy of Science and Technology Information, Hangzhou, China.

Insights

Chimeric antigen receptors (CARs) research is prestigious and globally biased. CARs therapies show strong science-invention links, but international collaboration varies inversely with country size.

Area of Science:

  • Biomedicine
  • Immunotherapy
  • Biotechnology

Background:

  • Chimeric antigen receptors (CARs)-based cell therapies have revolutionized biomedicine with significant preclinical and clinical success.
  • The scientific and inventive landscape, international cooperation, and research prestige of CARs have not been thoroughly explored.

Purpose of the Study:

  • To analyze the bibliometric and patent landscape of CARs research.
  • To assess publication metrics, subject areas, research hotspots, patent filing trends, and global contributions.

Main Methods:

  • Bibliometric analysis of 5,681 publications.
  • Machine learning-based text mining for research hotspots.
  • Analysis of 5,010 Inpadoc families for patent trends and rankings.

Main Results:

  • CARs research exhibits high prestige within the scientific community.
  • Significant global geographical bias observed in both academic output and patenting.
  • Strong science-invention links are evident, with notable country-specific variations.
  • An inverse relationship exists between country size and international collaboration rates.

Conclusions:

  • CARs research is characterized by high prestige, geographical concentration, and robust science-invention connections.
  • International collaboration patterns in CARs research are influenced by country size.
  • The findings provide insights into the global dynamics of CARs research and development.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.3K
Cell Culture01:21

Cell Culture

Most vertebrate cells grow in vitro attached to a substrate as a monolayer, called adherent cultures. The flasks and plates used to grow cells are chemically treated to facilitate cell attachment. However, a few cell types, such as hematopoietic cells, can grow in a suspension. In contrast to adherent cultures, suspension cultures can grow in non-treated cultureware using magnetic stirrers or spinner flasks to agitate the culture media
20.5K